GALNT14 and esophageal squamous cell carcinoma: Therefore, the main goals of this study were (i) to examine whether the chemoradiotherapeutic response was associated with survival benefits in advanced ESCC patients; and (ii) whether the GALNT14 genotypes were associated with the chemoradiotherapeutic response.